CD8A and intrahepatic cholangiocarcinoma: CD8+PD-1−EOMES− T cells, which lack expression of both PD-1 and EOMES, appear to be the best immune parameter among all examined which may potentially predict long-term survival in ICC (p = 0.007) (Fig. 3 and Table 1).